CordenPharma
Chris Burkitt, CPA, CA, currently serves as the Head of Group Controlling, Reporting & FP&A at Corden Pharma since July 2022. Previously, Chris held several key finance roles at Catalent Pharma Solutions, including Global Finance Manager for the A2R Catalyst Project and Finance Manager for Switzerland, overseeing significant sales across multiple business units. Additional experience includes interim management at PageGroup, financial leadership at Celestica, and various accounting positions at Stephenson's Rental Services, PEACE ARCH ENTERTAINMENT GRP, and Aluma Systems. Chris began a career in accounting with Shimmerman Penn LLP and Collins Barrow. Chris holds an Honours Bachelor of Business Administration in Accounting and Finance from Wilfrid Laurier University.
This person is not in any teams
This person is not in any offices
CordenPharma
1 followers
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com